4//SEC Filing
Johnston David Brannon 4
Accession 0001179110-18-008295
CIK 0000855654other
Filed
Jun 7, 8:00 PM ET
Accepted
Jun 8, 4:08 PM ET
Size
8.2 KB
Accession
0001179110-18-008295
Insider Transaction Report
Form 4
IMMUNOGEN INCIMGN
Johnston David Brannon
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2018-06-06$3.05/sh+10,000$30,500→ 190,690 total - Sale
Common Stock
2018-06-06$11.02/sh−10,000$110,200→ 180,690 total - Exercise/Conversion
Stock option (right to buy)
2018-06-06$3.05/sh−10,000$30,500→ 90,000 totalExercise: $3.05From: 2017-07-18Exp: 2026-07-18→ Common stock (10,000 underlying)
Footnotes (3)
- [F1]The transaction reported in this Form 4 was made pursuant to a 10(b)5-1 trading plan executed by the reporting person on March 7, 2018.
- [F2]Weighted average price of shares sold
- [F3]Exercisable in three equal installments over three years starting on the first year anniversary of the grant.
Documents
Issuer
IMMUNOGEN INC
CIK 0000855654
Entity typeother
Related Parties
1- filerCIK 0001486519
Filing Metadata
- Form type
- 4
- Filed
- Jun 7, 8:00 PM ET
- Accepted
- Jun 8, 4:08 PM ET
- Size
- 8.2 KB